Back to Results
First PageMeta Content
Accountancy / Fundamental analysis / BSE Sensex / Cipla / Valuation / Motilal Oswal Group / Earnings before interest /  taxes /  depreciation and amortization / EV/EBITDA / Escitalopram / Finance / Financial ratios / Economics


CIPLA[removed]MOSL-RU-8PG.p65
Add to Reading List

Document Date: 2013-02-08 04:53:41


Open Document

File Size: 214,17 KB

Share Result on Facebook

City

Indore / /

Company

Cipla No No No No / Cipla Cipla / U.S. Motilal Oswal Securities Limited / Cipla Medpro South Africa / P/E (x) Proposes / Meda / USD244m / Motilal Oswal Securities International Private Limited. / Singapore Motilal Oswal Capital Markets Singapore Pte Limited / Motilal Oswal Capital Markets Singapore Pte Limited / S&P / Teva / Bloomberg / USD350m / Motilal Oswal Securities Limited / /

Continent

Europe / /

Country

South Africa / Japan / United States / Australia / United Kingdom / Singapore / India / /

Currency

USD / /

/

Event

Business Partnership / FDA Phase / M&A / Earnings Announcement / /

IndustryTerm

investment services / contract manufacturing services / pharmaceutical groups / registered broker / manufacturing / pharmaceutical policy / /

Organization

Federal Aviation Administration / African Government / U.S. Securities and Exchange Commission / FINRA / FDA / NASD / /

Position

registered broker / exempt financial advisor / independent financial advisor / research analyst / Financial Advisors Regulations / Major Institutional Investors / player / earnings driver / growth driver / registered investment adviser / Analyst / dominant player / dealer / /

Product

AIDS / 2QFY13 / Dymista / INR6b / 1HFY13 / /

RadioStation

Core / /

Region

South Africa / Middle East / /

Technology

API / CMP / /

SocialTag